The ratios of CD14++CD80+ cells/CD14++CD163+ cells increased between IFP and SC within the OA group and the RA treated with bDMARDs group (p = 0.05835 and 0.8170, respectively). The gene discussed is CD163; the disease is rheumatoid arthritis.